Cardlytics
CDLX
89 hedge funds and large institutions have $40.4M invested in Cardlytics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 37 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
8.16% less ownership
Funds ownership: 54.92% → 46.76% (-8.2%)
10% less call options, than puts
Call options by funds: $634K | Put options by funds: $706K
18% less funds holding
Funds holding: 108 → 89 (-19)
22% less capital invested
Capital invested by funds: $52.1M → $40.4M (-$11.7M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
51% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$589K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$393K |
| 3 |
LPL Financial
San Diego,
California
|
+$327K |
| 4 |
LG
Lane Generational
Dover,
Massachusetts
|
+$294K |
| 5 |
Renaissance Technologies
New York
|
+$208K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.53M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.16M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$833K |
| 4 |
D.E. Shaw & Co
New York
|
-$616K |
| 5 |
Citigroup
New York
|
-$472K |
CDLX Hedge Fund Activity: Q2 2025 in Review
89 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2025, worth a combined $40.4M — down 22% from $52.1M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of CDLX and 18 opened new positions — a net loss of 19 holders — while 26 trimmed existing stakes and 26 added.
The largest buyer was GSA Capital Partners, adding an estimated $589K. The largest seller was BlackRock, cutting an estimated $3.53M.
- 89 institutional investors held Cardlytics (CDLX) as of Q2 2025, down from 108 in Q1 2025.
- Funds reported $40.4M of Cardlytics stock for Q2 2025, down 22% quarter-over-quarter.
- 18 funds opened new Cardlytics positions in Q2 2025 and 37 closed out, a net change of -19 holders.
- The largest Cardlytics buyer in Q2 2025 was GSA Capital Partners, an estimated $589K added.
- The largest Cardlytics seller in Q2 2025 was BlackRock, an estimated $3.53M sold.
Based on aggregated 13F filings for Q2 2025.